Large gap with delayed quotes
|
Last quote
03/02/2026
-
11:05:38
|
Bid
03/02/2026 -
11:05:03
|
Bid Volume |
Ask
03/02/2026 -
11:05:39
|
Ask Volume |
|---|---|---|---|---|
|
160.60
+1.20
(
+0.75% )
|
160.00
|
144 |
160.60
|
62 |
Analysis date: 27.02.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 14.11.2025.
Interest
Very weak
Very weak
One star since 03.02.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 16.01.2026 at a price of 164.80.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 03.02.2026.
4wk Rel Perf
-10.28%
-10.28%
The four-week dividend-adjusted underperformance versus STOXX600 is 10.28%.
Sensibility
Low
Low
Low, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by 0.01%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.07%.
Mkt Cap in $bn
4.13
4.13
With a market capitalization between $2 & $8bn, MEDACTA GROUP is considered a mid-cap stock.
G/PE Ratio
0.77
0.77
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
27.73
27.73
The estimated PE is for the year 2027.
LT Growth
20.80%
20.80%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.59%
0.59%
The twelve month estimated dividend yield represents 16.21% of earnings forecasts.
Beta
111
111
For 1% of index variation, the stock varies on average by 1.11%.
Correlation
0.52
0.52
52.09% of stock movements are explained by index variations.
Value at Risk
16.29
16.29
The value at risk is estimated at CHF 16.29. The risk is therefore 10.22%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
20.09.2019
20.09.2019